Back to results
CompletedPhase 3

A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer

NCT01526369

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Helsinki University Hopsital

Helsinki, Finland

+34 additional locations

View on ClinicalTrials.gov
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer — TrialFind